Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer

Gynecologic Oncology

Volumn 102, Issue 2, 2006, Pages 173-181

  Ueda, Masatsugu ^a   Hung, Yao Ching ^a,b   Chen, Jin Tang ^c   Chiou, Shiow Her ^d   Huang, Hsuan Hua ^c   Lin, Tze Yi ^e   Terai, Yoshito ^a   Chow, Kuan Chih ^d  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c FENG YUAN HOSPITAL   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^e Hsin Chu General Hospital   (Taiwan)

Author keywords

DDH; Drug resistance; HPV; Survival; Uterine cervical cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DIHYDRODIOL DEHYDROGENASE; DOCETANE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; PACLITAXEL; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

CELL LINE, TUMOR; CISPLATIN; DNA, VIRAL; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEOPLASM STAGING; OVARIAN NEOPLASMS; OXIDOREDUCTASES; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 33745902254     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.12.009     Document Type: Article

References (49)

1. Annual reports of the Department of Health, the Executive Yuan, Republic of China; 2003.
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
3. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 49 (1989) 4677-4681
4. Stoler M.H. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int. J. Gynecol. Pathol. 19 (2000) 16-28
5. Chan S.Y., Delius H., Halpern A.L., and Bernard H.U. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J. Virol. 69 (1995) 3074-3083
6. Breese P.L., Judson F.N., Penley K.A., and Douglas Jr. J.M. Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus. Sex. Transm. Dis. 22 (1995) 7-14
7. Scheffner M., Munger K., Byrne J.C., and Howley P.M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5523-5527
8. Nagai Y., Toma T., Moromizato H., Maehama T., Asato T., Kariya K., et al. Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy. Am. J. Obstet. Gynecol. 191 (2004) 1907-1913
9. Im S.S., Wilczynski S.P., Burger R.A., and Monk B.J. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin. Cancer Res. 9 (2003) 4145-4150
10. Yokoyama M., Iwasaka T., Nagata C., Nozawa S., Sekiya S., Hirai Y., et al. Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan. Cancer Lett. 192 (2003) 171-179
11. Hsu N.Y., Ho H.C., Chow K.C., Lin T.Y., Shih C.S., Wang L.S., et al. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res. 61 (2001) 2727-2731
12. Deng H.B., Parekh H.K., Chow K.C., and Simpkins H. Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells. J. Biol. Chem. 277 (2002) 15035-15043
13. Chen Y.J., Yuan C.C., Chow K.C., Wang P.H., Lai C.R., Yen M.S., et al. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients. Gynecol. Oncol. 97 (2005) 110-117
14. Wang L.S., Chow K.C., Wu Y.C., Hsu N.Y., and Lin T.Y. Inverse expressions of dihydrodiol dehydrogenase and glutathione-S-transferase in patients with esophageal squamous cell carcinoma. Int. J. Cancer 111 (2004) 246-251
15. Vogel K., Bentley P., Platt K.L., and Oesch F. Rat liver cytoplasmic dihydrodiol dehydrogenase. J. Biol. Chem. 255 (1980) 9621-9625
16. Shou M., Harvey R.G., and Penning T.M. Contribution of dihydrodiol dehydrogenase to the metabolism of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene in fortified rat liver subcellular fractions. Carcinogenesis 13 (1992) 1575-1582
17. Hara A., Taniguchi H., Nakayama T., and Sawada H. Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver. J. Biochem. (Tokyo) 108 (1990) 250-254
18. Ohara H., Nakayama T., Deyashiki Y., Hara A., Miyabe Y., and Tsukada F. Reduction of prostaglandin D2 to 9 alpha,11 beta-prostaglandin F2 by a human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isozyme. Biochim. Biophys. Acta 1215 (1994) 59-65
19. Kuzuya K. Chemoradiotherapy for uterine cancer: current status and perspectives. Int. J. Clin. Oncol. 9 (2004) 458-470
20. Remmele W., and Schicketanz K.H. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol. Res. Pract. 189 (1993) 862-866
21. Resnick R.M., Cornelissen M.T., Wright D.K., Eichinger G.H., Fox H.S., ter Schegget J., et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl. Cancer Inst. 82 (1990) 1477-1484
22. Schneeberger C., Speiser P., Kury F., and Zeillinger R. Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain. PCR Methods Appl. 4 (1995) 234-238
23. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., and Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharm. Bull. 19 (1996) 1518-1520
24. Chang J.T. An economic and efficient method of RNAi vector constructions. Anal. Biochem. 334 (2004) 199-200
25. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
26. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50 (1966) 163-170
27. Lacey Jr. J.V., Frisch M., Brinton L.A., Abbas F.M., Barnes W.A., Gravitt P.E., et al. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 12 (2001) 153-161
28. McIntyre-Seltman K., Castle P.E., Guido R., Schiffman M., Wheeler C.M., and ALTS Group. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1165-1170
29. Castle P.E., Hillier S.L., Rabe L.K., Hildesheim A., Herrero R., Bratti M.C., et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1021-1027
30. Iglesias M., Plowman G.D., and Woodworth C.D. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro. Am. J. Pathol. 146 (1995) 944-952
31. Tjiong M.Y., van der Vange N., ten Kate F.J., Tjong-A-Hung S.P., ter Schegget J., Burger M.P., et al. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol. Oncol. 73 (1999) 285-291
32. Castle P.E., Hildesheim A., Bowman F.P., Strickler H.D., Walker J.L., Pustilnik T., et al. Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels. J. Clin. Immunol. 22 (2002) 23-27
33. Waggoner S.E., and Wang X. Effect of nicotine on proliferation of normal, malignant, and human papillomavirus-transformed human cervical cells. Gynecol. Oncol. 55 (1994) 91-95
34. Tamura S., Fujimoto-Ouchi K., Mori K., Tanaka Y., and Ishitsuka H. Involvement of human interleukin 6 in experimental cachexia induced by a human uterine carcinoma xenograft. Clin. Cancer Res. 1 (1995) 1353-1358
35. Chow K.C., Chiou S.H., Ho S.P., Tsai M.H., Chen C.L., Wang L.S., et al. The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma. Oncol. Rep. 10 (2003) 813-819
36. Wang L.S., Chow K.C., and Wu Y.C. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. Scand. J. Gastroenterol. 37 (2002) 467-475
37. Kishimoto T. The biology of interleukin 6. Blood 74 (1990) 1-10
38. Tanner J., and Tosato G. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J. Clin. Invest. 88 (1991) 239-247
39. Castell J.V., Gomez-Lechon M.J., David M., Horano T., Kishimoto T., and Heinrich P.C. Acute phase responses of human hepatocytes: regulation of acute phase protein synthesis by IL-6. Hepatology 12 (1990) 1179-1186
40. Eppel W., Worda C., Frigo P., Manavi M., and Czerwenka K. The influence of cotinine on interleukin 6 expression in smokers with cervical preneoplasia. Acta Obstet. Gynecol. Scand. 79 (2000) 1105-1111
41. Hegde S., Pahne J., and Smola-Hess S. Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression. FASEB J. 18 (2004) 1439-1441
42. Morris H.H., Gatter K.C., Sykes G., Casemore V., and Mason D.Y. Langerhans' cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia. Br. J. Obstet. Gynaecol. 90 (1983) 412-420
43. Burczynski M.E., Harvey R.G., and Penning T.M. Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione. Biochemistry 37 (1998) 6781-6790
44. Burczynski M.E., Lin H.K., and Penning T.M. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res. 59 (1999) 607-614
45. Schiffman M.H., Haley N.J., Felton J.S., Andrews A.W., Kaslow R.A., Lancaster W.D., et al. Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res. 47 (1987) 3886-3888
46. Ax W., Soldan M., Koch L., and Maser E. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction. Biochem. Pharmacol. 59 (2000) 293-300
47. Shen H., Kauvar L., and Tew K.D. Importance of glutathione and associated enzymes in drug response. Oncol. Res. 9 (1997) 295-302
48. Uslu R., and Bonavida B. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum. Cancer 77 (1996) 725-732
49. Doroshow J.H., and Davies K.J. Redox cycling of anthracyclines by cardiac mitochondria: II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J. Biol. Chem. 261 (1986) 3068-3074